8-K
Current Report
Bolt Biotherapeutics, Inc. Filed Acc 0000950170-24-059524
Acquisition or sale completed · Exit or restructuring costs · Executive or director change
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.05 Costs associated with exit or disposal activities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading bolt-20240513.htm…